Knowledge Library

Abstract Multicolumn capture chromatography is gaining increased attention lately due to the significant economic and process advantages it offers compared with traditional batch mode chromatography. However, for wide adoption of this technology in clinical and commercial space, it requires scalable models for executing viral validation studies. In this study, viral validation studies were conducted under …Read More >

During BIO 2019, BioProcess International hosted a roundtable discussion on “Cell and Gene Therapies – Keep the work in-house or use a third party” at BPI Theater. It was moderated by BioProcess Insider editor Dan Stanton with industry leaders that included Felix Hsu, Senior Vice President and Global Head of WuXi Advanced Therapies, Celonic Group, …Read More >

“Gene therapy, a promising therapeutic approach that corrects disease-causing genetic errors, has spurred an arms race among the world’s largest pharmaceutical companies. Novartis (NYSE: NVS) announced the acquisition of AxeVis for a whopping $8.7 billion in 2018. Roche (NASDAQOTH: RHHBY) agreed to acquire gene therapy developer Spark Therapeutics for $4.8 billion in early 2019. One week …Read More >

NextUp: WuXi AppTec Is Speeding Up Drug Development Worldwide The Chinese pharma company, with its deep South Philadelphia Navy Yard presence, is globally recognized for building an innovative platform that shortens drug discovery and research and development time. By Queen Muse· 7/1/2019, 8:00 a.m. “NextUp” is a weekly NextHealth PHL feature that highlights the local …Read More >

This webcast features: Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Leachables from single use systems have the potential to impact the quality and safety of your drug product. This presentation will help you understand those risks and how to evaluate them, the current options for test methods and what the future holds …Read More >